Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André B Kind

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Praxis|November 18, 2016
André B Kind
Praxis|August 8, 2019
André B Kind
Current Problems in Dermatology|March 20, 2014
Management of human papillomavirus-related gynecological malignanciesViola A Heinzelmann-Schwarz, André B Kind, Francis Jacob
Swiss Medical Weekly|February 8, 2020
Reply to comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647Simon Wieser, Marion Schmidt, André B Kind, et al.
Swiss Medical Weekly|August 25, 2018
Ovarian cancer in Switzerland: incidence and treatment according to hospital registry dataSimon Wieser, Marion Schmidt, André B Kind, et al.
Molecular Oncology|October 5, 2020
High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancerFrancis Jacob, Rosa Lina Marchetti, André B Kind, et al.
BMC Public Health|May 14, 2020
Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in SwitzerlandAndré B Kind, Andrew Pavelyev, Smita Kothari, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2020
Sexually transmitted coinfections in patients with anogenital warts - a retrospective analysis of 196 patientsSimon M Mueller, Sheryl Menzi, André B Kind, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2020
Simon M Mueller, Sheryl Menzi, André B Kind, et al.
Journal of Cancer Research and Clinical Oncology|January 30, 2020
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?Viola Heinzelmann-Schwarz, André B Kind, Marcus Vetter, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Praxis|November 18, 2016
André B Kind
Praxis|August 8, 2019
André B Kind
Current Problems in Dermatology|March 20, 2014
Management of human papillomavirus-related gynecological malignanciesViola A Heinzelmann-Schwarz, André B Kind, Francis Jacob
Swiss Medical Weekly|February 8, 2020
Reply to comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647Simon Wieser, Marion Schmidt, André B Kind, et al.
Swiss Medical Weekly|August 25, 2018
Ovarian cancer in Switzerland: incidence and treatment according to hospital registry dataSimon Wieser, Marion Schmidt, André B Kind, et al.
Molecular Oncology|October 5, 2020
High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancerFrancis Jacob, Rosa Lina Marchetti, André B Kind, et al.
BMC Public Health|May 14, 2020
Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in SwitzerlandAndré B Kind, Andrew Pavelyev, Smita Kothari, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2020
Sexually transmitted coinfections in patients with anogenital warts - a retrospective analysis of 196 patientsSimon M Mueller, Sheryl Menzi, André B Kind, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2020
Simon M Mueller, Sheryl Menzi, André B Kind, et al.
Journal of Cancer Research and Clinical Oncology|January 30, 2020
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?Viola Heinzelmann-Schwarz, André B Kind, Marcus Vetter, et al.
Pageof 2